Begleiter Asher, Lange Laurie
Manitoba Institute of Cell Biology, CancerCare Manitoba, Winnipeg, Manitoba R3E 0V9, Canada.
Int J Oncol. 2002 Apr;20(4):835-8.
DT-diaphorase is a two-electron reducing enzyme that is an important detoxifying enzyme and activator of bioreductive antitumor agents. Expression of the DT-diaphorase gene, NQO1, appears to be transcriptionally regulated, and the gene is induced by a wide variety of compounds. We showed that 1,2-dithiole-3-thione can selectively increase DT-diaphorase activity in human and murine tumors, and that this enhanced the antitumor activity of bioreductive antitumor agents. However, we found that DT-diaphorase activity was not increased in some human tumor cell lines after treatment with the inducer, and this appeared to be due to a lack of increased transcription. To determine if this lack of increased transcription was due to a mutation in the promoter region of the NQO1 gene in these cells, we sequenced approximately 2000 bases of the NQO1 promoter region from non-induced cells and compared these with sequences from human HT29 colon cancer cells, which showed significant increases in NQO1 transcription, and the sequence reported for human liver cells in Genbank. Sequence analysis showed no changes in the sequences of the major transcriptional elements, XRE, CAT box, ARE, AP1 site or AP2 site, in the tumor cells compared with the Genbank sequences. The only major change was a deletion of a 20 base repeat region approximately 400 bases 5' to the XRE element in all the cells, including the HT29 cells, compared with the sequence reported in Genbank. There were also several insertions of a single base in various parts of the sequences which occurred in most, or all, of the cell lines compared with the reported sequence, and a small number of single base changes, insertions or deletions that occurred in a single cell line. However, these changes did not appear to correlate with differences in induced transcription of the NQO1 gene. These results suggest that the differences in transcription of the NQO1 gene after treatment with DT-diaphorase inducers was not due to alterations in the promoter region of the gene.
DT-黄递酶是一种双电子还原酶,是一种重要的解毒酶和生物还原抗肿瘤药物的激活剂。DT-黄递酶基因NQO1的表达似乎受到转录调控,该基因可被多种化合物诱导。我们发现,1,2-二硫杂环戊烯-3-硫酮可选择性增加人和鼠肿瘤中的DT-黄递酶活性,这增强了生物还原抗肿瘤药物的抗肿瘤活性。然而,我们发现,在用诱导剂处理后,一些人肿瘤细胞系中的DT-黄递酶活性并未增加,这似乎是由于转录未增加所致。为了确定这种转录未增加是否是由于这些细胞中NQO1基因启动子区域的突变,我们对未诱导细胞的NQO1启动子区域约2000个碱基进行了测序,并将其与人类HT29结肠癌细胞(其NQO1转录显著增加)的序列以及Genbank中报道 的人类肝细胞序列进行了比较。序列分析表明,与Genbank序列相比,肿瘤细胞中主要转录元件XRE、CAT框、ARE、AP1位点或AP2位点的序列没有变化。唯一的主要变化是,与Genbank中报道的序列相比,在所有细胞(包括HT29细胞)中,XRE元件5'端约400个碱基处的一个20碱基重复区域缺失。与报道的序列相比,在大多数或所有细胞系的序列的不同部位还存在几个单碱基插入,以及在单个细胞系中发生的少量单碱基变化、插入或缺失。然而,这些变化似乎与NQO1基因诱导转录的差异无关。这些结果表明,用DT-黄递酶诱导剂处理后NQO1基因转录的差异不是由于该基因启动子区域的改变所致。